Literature DB >> 35705841

Duck sewage source coliphage P762 can lyse STEC and APEC.

Xuewei Kong1,2,3, Hui Wang1,2,3, Genglin Guo1,2,3, Pei Li1,2,3, Panpan Tong4, Maojun Liu5, Xun Ma6, Chen Dong7, Yubao Li8, Haiyan Zhang9, Wei Zhang10,11,12.   

Abstract

Multiple pathogenic types or serotypes restrict treatment for colibacillosis. In addition, rising antibiotic resistance has heightened public awareness to prevent and control pathogenic Escherichia coli. The bacteriophage is a viable technique to treat colibacillosis as an alternative to antibiotics. P762, a coliphage isolated from duck farm sewage, was demonstrated to cloud lyse Shiga toxin-producing Escherichia Coli serotypes O157 and non-O157 (17/39), Avian pathogenic E. coli covered serotype O78, O83, and O9 (5/19), and other pathogenic Escherichia coli (5/17). Additional fundamental biological characteristics analysis revealed that P762 is stable at pH 3 ~ 11 and temperature between 4 °C and 60 °C, and its optimum multiplicity of infection (MOI) is 0.1. The one-step curve of P762 exhibited three bursts of growth stage: two rapid and one slow stage. Furthermore, the first rapid burst size is 80 CFU/PFU, the burst size of the slow stage is 10 CFU/PFU, and the second rapid burst size is about 990 CFU/PFU. In addition, P762 can form a "halo" on a double agar plate, implying that the phage secretes depolymerase. With 95.14% identity and 90% query coverage, genome sequence analysis revealed that P762 is most closely related to Escherichia phage DY1, which belongs to the genus Kayfunavirus. After screening using RAST and VFDB, no virulence factors were discovered in P762. In vitro antibacterial tests revealed that P762 has high bactericidal activity in lettuce leaves contaminated with STEC. In conclusion, phage P762 might be employed in the future to prevent and control pathogenic Escherichia coli.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  APEC; Bacteriophage; Pan-genome; Phage therapy; STEC

Mesh:

Substances:

Year:  2022        PMID: 35705841     DOI: 10.1007/s11262-022-01915-7

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  42 in total

Review 1.  Host specificity of septicemic Escherichia coli: human and avian pathogens.

Authors:  Eliora Z Ron
Journal:  Curr Opin Microbiol       Date:  2005-12-27       Impact factor: 7.934

2.  On an invisible microbe antagonistic toward dysenteric bacilli: brief note by Mr. F. D'Herelle, presented by Mr. Roux. 1917.

Authors:  Felix D'Herelle
Journal:  Res Microbiol       Date:  2007-07-28       Impact factor: 3.992

3.  Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.

Authors:  John T Brooks; Evangeline G Sowers; Joy G Wells; Katherine D Greene; Patricia M Griffin; Robert M Hoekstra; Nancy A Strockbine
Journal:  J Infect Dis       Date:  2005-09-14       Impact factor: 5.226

Review 4.  Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission.

Authors:  Alfredo Caprioli; Stefano Morabito; Hubert Brugère; Eric Oswald
Journal:  Vet Res       Date:  2005 May-Jun       Impact factor: 3.683

5.  Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.

Authors:  Kirk E Smith; Peter R Wilker; Paul L Reiter; Erin B Hedican; Jeff B Bender; Craig W Hedberg
Journal:  Pediatr Infect Dis J       Date:  2012-01       Impact factor: 2.129

Review 6.  Molecular mechanisms of Escherichia coli pathogenicity.

Authors:  Matthew A Croxen; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

Review 7.  Escherichia coli 0157:H7: an update on intestinal colonization and virulence mechanisms.

Authors:  Rodney A Moxley
Journal:  Anim Health Res Rev       Date:  2004-06       Impact factor: 2.615

8.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

Review 9.  A century of the phage: past, present and future.

Authors:  George P C Salmond; Peter C Fineran
Journal:  Nat Rev Microbiol       Date:  2015-11-09       Impact factor: 60.633

10.  Occurrence of Escherichia coli O157:H7 in cattle feces and contamination of carcass and various contact surfaces in abattoir and butcher shops of Hawassa, Ethiopia.

Authors:  Biruhtesfa Atnafie; Degmawi Paulos; Mesele Abera; Genene Tefera; Dereje Hailu; Surafel Kasaye; Kebede Amenu
Journal:  BMC Microbiol       Date:  2017-01-25       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.